The prevalence of elevated low-density lipoprotein cholesterol has declined recently, but millions of Americans still have levels for which treatment is recommended or should be considered and many remain untreated.
A quality improvement project using mobile diabetic retinopathy screening units for people with type 2 diabetes significantly raised screening rates and improved patient knowledge.
Subcutaneous efgartigimod PH20 SC is effective and tolerable for the treatment of CIDP, providing a convenient alternative to intravenous and other older treatments.
Access to care for the highly preventable disease is thought to be behind why Black Americans are 20% more likely to receive a colorectal cancer diagnosis than any other racial or ethnic group.